In this interview, News Medical speaks with Guillaume Bentzinger, Project Manager at Novalix; Luis Carrillo, Managing Director at De Dietrich France; Philippe Robin CEO of Alysophil; and Alejandro ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

Novo Nordisk (NVO) has pledged DKK 42B ($6B) from 2023 through the next six years to expand production capacity in its home country. The investment will go into ramping up production at existing ...

Bruker is hosting a webinar that will examine the PIPAc project in more detail. This exciting initiative is reshaping pharmaceutical manufacturing by combining AI, in-line NMR, flow chemistry, and ...

API security has been a growing concern for years. However, while it was always seen as important, it often came second to application security or hardening infrastructure.  In 2025, the picture ...

Emzor Pharmaceutical Industries Limited, a leading pharmaceutical company in Nigeria, has announced a ground-breaking $230 million investment in a new Active Pharmaceutical Ingredients (API) ...